Illumina is the leader in next generation DNA sequencing—the newest wave of high-throughput genetic analyzers. LUNAR has worked with Illumina since its inception to enhance its brand with the development of a cohesive design language. The deep collaboration between the companies has resulted in building better solutions that simplify the complex workflow within this equipment’s environment. Illumina sequencers like the NextSeq 500 are the gold standard in highthroughput analysis. It cost $3 billion to decode the first human genome. A decade ago the cost was $250,000. The NextSeq 500 can do it for $1,000 each. Illumina’s machines will help solve the mysteries of how genes are corrupted and predispose patients to diseases. This will open the door to preventing many diseases that have left the medical field flummoxed.